Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use VYSCOXA safely and effectively. See full prescribing information for VYSCOXA. VYSCOXA TM (celecoxib) oral suspension, Initial U.S. Approval: 1998
Medication labelWhy this: Advisory · dailymed-prescription
VYSCOXA is indicated In adults for the management of the signs and symptoms of: (OA) [see Clinical Studies (14.1) ]. (RA) [see Clinical Studies (14.2) ]. (AS) [see Clinical Studies (14.3) ]. In pediatric patients two years of age and older for the management of the signs and symptoms of: (JRA) [see Clinical Studies (14.4) ]. Limitations of Use VYSCOXA must be administered on an empty stomach at least 2 hours before or 1 hour after food. Taking VYSCOXA with food results in plasma exposures of celecoxib up to 50% higher than intended. If patients cannot tolerate VYSCOXA in the fasted state, discontinue use of VYSCOXA (reference Sections 2.1 , 5, 12). VYSCOXA is NOT indicated for the management of acute pain or treatment of primary dysmenorrhea.
- generic_name
- celecoxib
- product_names
- Celecoxib
- ndc
- 15370-501, 15370-501-16
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en